Linagliptin is more effective than glimepiride at achieving a composite outcome of target HbA1c < 7% with no hypoglycaemia and no weight gain over 2years

DSpace Repository

Show simple item record

dc.contributor.author Gallwitz, Baptist
dc.date.accessioned 2013-12-16T09:29:22Z
dc.date.available 2013-12-16T09:29:22Z
dc.date.issued 2013
dc.identifier.issn 1368-5031
dc.identifier.uri http://hdl.handle.net/10900/39608
dc.language.iso en en
dc.publisher Wiley - Blackwell de_DE
dc.relation.uri http://dx.doi.org/10.1111/ijcp.12101 de_DE
dc.rights info:eu-repo/semantics/closedAccess
dc.subject.ddc 610 de_DE
dc.title Linagliptin is more effective than glimepiride at achieving a composite outcome of target HbA1c < 7% with no hypoglycaemia and no weight gain over 2years de_DE
dc.type Article de_DE
utue.quellen.id 20130911224530_01349 de_DE
utue.publikation.seiten 317-321 de_DE
utue.personen.roh Gallwitz, B.
utue.personen.roh Rosenstock, J.
utue.personen.roh Emser, A.
utue.personen.roh von Eynatten, M.
utue.personen.roh Woerle, H-J.
dcterms.isPartOf.ZSTitelID International Journal of Clinical Practice de_DE
dcterms.isPartOf.ZS-Issue 4 de_DE
dcterms.isPartOf.ZS-Volume 67 de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record